Skip to main content

Table 3 Mean (SEM) percentage changes from baseline in Multiple Sclerosis Self-Efficacy Scale (MSSES) and Impact on Participation and Autonomy (IPA) scores at 1, 3 and 6 months after SCDP in the total group and in the Relapsing Remitting (RR) and Progressive (P) subgroups

From: Improved self-efficacy in persons with relapsing remitting multiple sclerosis after an intensive social cognitive wellness program with participation of support partners: a 6-months observational study

  1 month 3 months 6 months
  Total RR SP/PP Total RR SP/PP Total RR SP/PP
MSSES-Function 4.5% (4.1) 0.9% (10.0) 15.1% (47.2) −0.2% (5.2) 6.2% (21.9) 5.3% (51.1) 1.4% (4.8) 1.2% (12.9) 1.5% (40.7)
MSSES-Control 10.0% (6.1) 3.8% (30.0) 15.1% (47.2) 8.0% (8.4) −0.2% (33.9)% 15.5% (68.3) 23.4% (9.5) 24.8%* (37.2) 22.1% (75.2)
IPA-Limitations −4.1% (2.4) −3.8% (18.6) −4.6% (14.1) −3.3% (2.6) −6.3% (13.6)% −0.7% (18.8) −3.1% (2.8) −5.3% (19.3) −1.1% (15.9)
IPA-Problems −3.4% (2.5) −6.0% (17.0) −1.7% (15.2) −6.5% (2.9) −8.4%* (18.35) −4.9% (17.4) −2.2% (3.3) −3.9% (22.5) −0.8% (18.1)
  1. *, P < 0.01.